documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
21 rows where docket_id = "FDA-2021-N-0862" and posted_year = 2024 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, last_modified, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2021-N-0862-0219 | FDA | None FDA-2021-N-0862 | Reference 10 - FDA Combination Products web page | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2025-02-23T18:35:38Z | 0 | 0 | 090000648688c405 | |||
| FDA-2021-N-0862-0226 | FDA | None FDA-2021-N-0862 | Reference 18 - 73 FR 63491_Docket FDA-2008-N-0549_10-24-2008 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T20:00:49Z | 0 | 0 | 090000648688c497 | |||
| FDA-2021-N-0862-0227 | FDA | None FDA-2021-N-0862 | Reference 19 - 83 FR 40973_Docket FDA-2017-N-6730_08-17-2018 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T20:00:54Z | 0 | 0 | 090000648688c4a8 | |||
| FDA-2021-N-0862-0215 | FDA | None FDA-2021-N-0862 | Reference 7a - NPSA_Guide to Graphic Design of Medication Packaging 2nd Ed_2007 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:59:19Z | 0 | 0 | 090000648688c3cb | |||
| FDA-2021-N-0862-0218 | FDA | None FDA-2021-N-0862 | Reference 9 - FDA eCTD Resources web page | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2025-02-23T18:35:38Z | 0 | 0 | 090000648688c403 | |||
| FDA-2021-N-0862-0223 | FDA | None FDA-2021-N-0862 | Reference 15 - 83 FR 13394_Docket FDA-2008-N-0549_04-02-2018 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T20:00:19Z | 0 | 0 | 090000648688c490 | |||
| FDA-2021-N-0862-0225 | FDA | None FDA-2021-N-0862 | Reference 17 - 87 FR 68702_Docket FDA-2022-N-2673_11-16-2022 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T20:00:41Z | 0 | 0 | 090000648688c493 | |||
| FDA-2021-N-0862-0220 | FDA | None FDA-2021-N-0862 | Reference 11 - MOU Between the FTC and FDA Concerning the Exchange of Information (FDA-225-71-8003)_April 1971 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:59:53Z | 0 | 0 | 090000648688c406 | |||
| FDA-2021-N-0862-0217 | FDA | None FDA-2021-N-0862 | Reference 8 - USP_Recommendations to the Safe Medication Use Expert Committee by the Health Literacy and Prescription Container Labeling Advisory Panel_2010 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:59:32Z | 0 | 0 | 090000648688c402 | |||
| FDA-2021-N-0862-0208 | FDA | None FDA-2021-N-0862 | Reference List - Nonprescription Drug Product With an Additional Condition for Nonprescription Use - Final Rule | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:58:28Z | 0 | 0 | 090000648688c868 | |||
| FDA-2021-N-0862-0207 | FDA | None FDA-2021-N-0862 | Nonprescription Drug Product With an Additional Condition for Nonprescription Use | Rule | Final Rule | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T05:00:00Z | 2024-12-26T15:41:32Z | 2024-30261 | 0 | 0 | 090000648688bfbc | |
| FDA-2021-N-0862-0216 | FDA | None FDA-2021-N-0862 | Reference 7b - NPSA_Guide to Labelling and Packaging of Injectable Medicines_1st Ed_2007 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:59:23Z | 0 | 0 | 090000648688c3cc | |||
| FDA-2021-N-0862-0209 | FDA | None FDA-2021-N-0862 | Reference 1 - FDA Guidance for Industry_Label -Comprehension-Studies-for-Nonprescription-Drug-Products_Aug2010 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:58:33Z | 0 | 0 | 090000648688c8ae | |||
| FDA-2021-N-0862-0212 | FDA | None FDA-2021-N-0862 | Reference 4 - FDA Guidance for Industry and FDA Staff_Policy for Device Software Functions and Mobile Medical Applications | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:58:49Z | 0 | 0 | 090000648688c8b3 | |||
| FDA-2021-N-0862-0213 | FDA | None FDA-2021-N-0862 | Reference 5 - FDA Medwatch The FDA Safety Information and Adverse Event Reporting Program | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2025-02-23T18:35:38Z | 0 | 0 | 090000648688c3c7 | |||
| FDA-2021-N-0862-0221 | FDA | None FDA-2021-N-0862 | Reference 12 - FDA Prescription to Over-the-Counter (OTC) Switch List web page | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2025-02-23T18:35:37Z | 0 | 0 | 090000648688c407 | |||
| FDA-2021-N-0862-0211 | FDA | None FDA-2021-N-0862 | Reference 3 - FDA Guidance for Industry_Application of Human Factors Engineering Principles for Combination Products QA_Sept2023 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:58:45Z | 0 | 0 | 090000648688c8b1 | |||
| FDA-2021-N-0862-0222 | FDA | None FDA-2021-N-0862 | Reference 14 - 87 FR 38313_Docket FDA-2021-N-0862_06-28-2022 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T20:00:08Z | 0 | 0 | 090000648688c986 | |||
| FDA-2021-N-0862-0224 | FDA | None FDA-2021-N-0862 | Reference 16 - 70 FR 52050_Docket 2005N-0345_09-01-2005 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T20:00:32Z | 0 | 0 | 090000648688c491 | |||
| FDA-2021-N-0862-0210 | FDA | None FDA-2021-N-0862 | Reference 2 - FDA Guidance for Industry_Self-Selection-Studies-for-Nonprescription-Drug-Products_April2013 | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T19:58:41Z | 0 | 0 | 090000648688c8b0 | |||
| FDA-2021-N-0862-0214 | FDA | None FDA-2021-N-0862 | Reference 6 - FDA Consumer Complaint Coordinators web page | Supporting & Related Material | Background Material | 2024-12-26T05:00:00Z | 2024 | 12 | 2025-02-23T18:35:38Z | 0 | 0 | 090000648688c3c8 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;